Taiwan-Silicon Valley Biomedical Conference Program     06/05/2004

 

8:00AM

Registration / Networking

9:00AM      

Welcome/ Introduction

Moderator: Dr. Li-chung Lee, ITRI,Inc.

 

Opening Remarks

Dr. Ching-Yen Tsai, Minister without portfolio, Executive Yuan, ROC

Dr. Johnsee Lee, President, ITRI, Taiwan

SESSION 1

9:20AM

Theme: Strategies for the Development of Biomedical Industries

Moderator: Dr. Yue-Teh Jang, General Partner, The Vertical Group

A Multi-disciplinary Approach to Building a Successful Medical Device Industry

Dr. Paul G.. Yock, M.D., Professor of Medical and Mechanical Engineering, Stanford University.

Biotech-The Rising Star After The High Tech Bubble?

Dr. Bryan E. Roberts, General Partner, Venrock Associates

Leapfrogging Strategy for of Biotech Industry in Asia

Dr. Frank Kung, Managing General Partner, BioAsia

11:00AM     

Morning Break

SESSION 2

11:20AM

Theme: Striding Toward the Globalization

~ The Present and Future of Taiwan’s Biotech Industry Development

 

Moderator—Dr. Ching-Yen Tsai, Minister without portfolio, Executive Yuan, ROC

Plenary speakers

Government Policies and Strategies on Biotech Development

Dr. Mei-Hsueh Lin, Science and Technology Advisory Group of Executive Yuan, ROC (tentative)

Leveraging Taiwan’s Advantages for Global Biotech Competitiveness

Dr. Johnsee Lee, President of ITRI

Biotech Partnering Strategies – from Taiwan to the World

Dr. Jui-Lien Huang, President of DCB

Taiwan-Your Partner for Globalization and Localization

Mr. David Liu, Vice President of TAITRA

12:10PM

Lunch , Networking & Exhibition

SESSION 3

2:00PM

Theme: Building a Successful Global Biomedical Industry

Moderator: Dr. Kenneth Fong, Chairman, Kenson Ventures, LLC.

 

Bridging the ‘Valley of Death’: New Approaches and Models for Pharmaceutical Drug Development in the US and Asia

Dr. Glenn Rice, VP, Biosciences Division, SRI International

Diagnostics for the Real World

Dr. Helen H. Lee, President & CEO, Diagnostics for the Real World, Ltd.

Accelerating Development of Taiwan Pharmaceutical Industry

Dr. Ming-Chu Hsu, President & CEO, TaiGen Biotechnology Company Ltd.

From Product Concept To The Market Leader

Dr. Karen Talmadge, Executive VP& CSO, Kyphon Inc.

4:00PM

Afternoon Break

SESSION 4

4:20PM

Panel Discussion:

Critical Issues of Cross-Pacific Business Alliance and Technology Collaboration

Moderator: Dr. Yue-Teh Jang, General Partner, The Vertical Group

 

Panelist:

   Dr. Johnsee Lee, President,Taiwan Bio Industry Organization

Dr. KeeLung Hong, Founder and CTO, Hermes Biotech

Dr. Por Lai, President, President Life, Taiwan

David Saul, J.D., Partner, Wilson Sonsini Goodrich & Rosati

Dr. Tony Chou, M.D., General Manager, Abbott Laboratories

5:20PM

Adjourn